Wal-Mart to carry Hooper Holmes’ hemoglobin A1 test
BASKING RIDGE, N.J. Hooper Holmes earlier this month launched a new home-testing product under Wal-Mart’s store brand, Roy Bubbs, Hooper president and chief executive officer, told analysts during a conference call last week.
“Our first product is a hemoglobin A1 test which helps diabetics measure the effectiveness of their treatment plan every two to three months,” he said. “While this will not contribute significantly in new revenues in ‘08, we’re excited that Wal-Mart has taken our product line into their stores which will appear under their own brand name. And in fact, it should be reaching their shelves very soon.”
Folic acid/B vitamin combo shows no reduced rate of cardio events
CHICAGO Women at high-risk of cardiovascular disease who took a daily supplement of folic acid and vitamin B6 and B12 for seven years did not have an overall reduced rate of cardiovascular events, despite a significant lowering of homocysteine levels, according to a study in the May 7 issue of the Journal of the American Medical Association.
“Homocysteine [an amino acid produced by the body] levels have been directly associated with cardiovascular risk in observational studies; and daily supplementation with folic acid, vitamin B6, vitamin B12, or a combination have been shown to reduce homocysteine levels to varying degrees in intervention studies,” the authors noted. Observational data suggest cardiovascular benefits from B-vitamin supplementation may be greater among women, yet women have been underrepresented in published randomized trials.
Christine Albert of Brigham and Women’s Hospital and Harvard Medical School, Boston, and colleagues tested whether a combination of folic acid, vitamin B6 and vitamin B12 would reduce total cardiovascular events among women at high risk for the development of cardiovascular disease over 7 years of follow-up. Within an ongoing randomized trial of antioxidant vitamins, 5,442 women who were U.S. health professionals age 42 years or older, with either a history of CVD or three or more coronary risk factors, were enrolled in a randomized trial to receive a combination pill containing folic acid (2.5 mg), vitamin B6 (50 mg), and vitamin B12 (1 mg) or a matching placebo.
“Our results are consistent with prior randomized trials performed primarily among men with established vascular disease and do not support the use of folic acid and B vitamin supplements as preventive interventions for CVD in these high-risk fortified populations,” the authors noted.
Cooley, Core-Mark to distribute FIX Hangover Strips throughout Nevada
HealthSport on Tuesday announced that its wholly-owned subsidiary, Cooley Nutraceuticals, has entered into a distribution agreement with Core-Mark International for its FIX Hangover Strips product for Las Vegas and the entire state of Nevada.
“It’s exciting and a huge honor to be partnering with a company of Core-Mark’s caliber,” stated Clay Cooley, president of Cooley Nutraceuticals. “This relationship will allow us to expand substantially beyond our initial Las Vegas presence at the Palms and Hard Rock hotels, and lay the foundation to capitalize on Core-Mark’s nationwide distribution capabilities.’’
Core-Mark provides distribution and logistics services as well as marketing programs to more than 20,000 retail locations in 46 states and 5 Canadian provinces through its 25 distribution centers. Core-Mark services traditional convenience retailers, grocers, mass merchandisers, drug, liquor and specialty stores, and other stores that carry consumer packaged goods.